ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,852.40
0.30%
다우존스 지수
40,211.72
0.53%
Bitcoin
63,587.57
4.62%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Boundless Bio Inc (BOLD)

  7. Boundless Bio Inc (BOLD) 뉴스

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BOLD
일자시간출처헤드라인심볼기업
2019/02/1406:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
2019/02/1401:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
2019/02/1320:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
2019/02/1223:44Edgar (US Regulatory)Schedule 13gNASDAQ:BOLDBoundless Bio Inc
2019/02/0908:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0908:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0908:00PR Newswire (US)Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0907:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0907:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0907:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0907:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0907:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0907:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0907:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/0907:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/01/3122:00PR Newswire (US)Audentes Therapeutics Announces Next Steps in the Development of AT132 to Treat XLMTM Following Collaborative Initial Meeting...NASDAQ:BOLDBoundless Bio Inc
2019/01/0722:00PR Newswire (US)Audentes Therapeutics Reports on Recent Progress and Outlines 2019 Key PrioritiesNASDAQ:BOLDBoundless Bio Inc
2019/01/0508:00PR Newswire (US)Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2019/01/0506:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/01/0506:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BOLDBoundless Bio Inc
2019/01/0322:00PR Newswire (US)Audentes Therapeutics Appoints Eric B. Mosbrooker as Senior Vice President and Chief Commercial OfficerNASDAQ:BOLDBoundless Bio Inc
2019/01/0222:00PR Newswire (US)Audentes Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
2018/12/2807:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/12/1106:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/12/0808:00PR Newswire (US)Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2018/11/1708:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/11/1708:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/11/1708:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/11/0722:00PR Newswire (US)Audentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
2018/11/0720:21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
 검색 관련기사 보기:NASDAQ:BOLD

최근 히스토리

PM
XAUUSD
Gold vs US Dollar
NYSE
AXP
American Express
NASDAQ
NVDA
NVIDIA
NYSE
BAC
Bank of America
USI
USTECH100
US Tech 100
FX
USDJPY
US Dollar vs Yen
AMEX
SPY
SPDR S&P 500
SPI
SP500
S&P 500
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
NASDAQ
AMZN
Amazon.com
CCOM
US30
US 30
FX
USDGBP
US Dollar vs Sterling
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유